Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI

Open-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients With MPS VI

Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VI

Study of rhASB in Patients With Mucopolysaccharidosis VI

A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI

Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease

ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program